Literature DB >> 31060088

Fluid Management in Acute Respiratory Distress Syndrome.

Jonathan D Casey1, Matthew W Semler1, Todd W Rice1.   

Abstract

One of the defining features of acute respiratory distress syndrome (ARDS) is noncardiogenic pulmonary edema, resulting from increased permeability of the alveolar-capillary barrier and passage of protein-rich fluid into the interstitium and alveolar spaces. The loss of protein from the intravascular space disrupts the normal oncotic pressure differential and causes patients with ARDS to be particularly sensitive to the hydrostatic forces that correlate with intravascular volume. Conservative fluid management, in which diuretics are administered and intravenous fluid administration is minimized, may decrease hydrostatic pressure and increase serum oncotic pressure, potentially limiting the development of pulmonary edema. However, the cause of death in most patients with ARDS is multiorgan system failure, not hypoxemia, and the impact of conservative fluid management on the incidence of extrapulmonary organ failure during ARDS is unclear. These physiologic observations have led to a series of studies examining the impact of fluid management on the development of, resolution of, survival from, and long-term outcomes from ARDS. While questions remain, the current literature makes it clear that fluid management is an integral part of the care of patients with ARDS. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31060088      PMCID: PMC6546102          DOI: 10.1055/s-0039-1685206

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  78 in total

1.  Age of transfused blood in critically ill adults.

Authors:  Jacques Lacroix; Paul C Hébert; Dean A Fergusson; Alan Tinmouth; Deborah J Cook; John C Marshall; Lucy Clayton; Lauralyn McIntyre; Jeannie Callum; Alexis F Turgeon; Morris A Blajchman; Timothy S Walsh; Simon J Stanworth; Helen Campbell; Gilles Capellier; Pierre Tiberghien; Laurent Bardiaux; Leo van de Watering; Nardo J van der Meer; Elham Sabri; Dong Vo
Journal:  N Engl J Med       Date:  2015-03-17       Impact factor: 91.245

2.  Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization.

Authors:  J P Mitchell; D Schuller; F S Calandrino; D P Schuster
Journal:  Am Rev Respir Dis       Date:  1992-05

3.  Relationship between Race and the Effect of Fluids on Long-term Mortality after Acute Respiratory Distress Syndrome. Secondary Analysis of the National Heart, Lung, and Blood Institute Fluid and Catheter Treatment Trial.

Authors:  Sarah E Jolley; Catherine L Hough; Gilles Clermont; Douglas Hayden; Suqin Hou; David Schoenfeld; Nicholas L Smith; Boyd Taylor Thompson; Gordon R Bernard; Derek C Angus
Journal:  Ann Am Thorac Soc       Date:  2017-09

4.  Formation and validation of a telephone battery to assess cognitive function in acute respiratory distress syndrome survivors.

Authors:  Jason D Christie; Rosette C Plotkin Biester; Darren B Taichman; William H Shull; John Hansen-Flaschen; Judy A Shea; Ramona O Hopkins
Journal:  J Crit Care       Date:  2006-06       Impact factor: 3.425

Review 5.  The acute respiratory distress syndrome: pathogenesis and treatment.

Authors:  Michael A Matthay; Rachel L Zemans
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

6.  Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes.

Authors:  Kathleen D Liu; B Taylor Thompson; Marek Ancukiewicz; Jay S Steingrub; Ivor S Douglas; Michael A Matthay; Patrick Wright; Michael W Peterson; Peter Rock; Robert C Hyzy; Antonio Anzueto; Jonathon D Truwit
Journal:  Crit Care Med       Date:  2011-12       Impact factor: 7.598

7.  Liberal Versus Restrictive Intravenous Fluid Therapy for Early Septic Shock: Rationale for a Randomized Trial.

Authors:  Wesley H Self; Matthew W Semler; Rinaldo Bellomo; Samuel M Brown; Bennett P deBoisblanc; Matthew C Exline; Adit A Ginde; Colin K Grissom; David R Janz; Alan E Jones; Kathleen D Liu; Stephen P J Macdonald; Chadwick D Miller; Pauline K Park; Lora A Reineck; Todd W Rice; Jay S Steingrub; Daniel Talmor; Donald M Yealy; Ivor S Douglas; Nathan I Shapiro
Journal:  Ann Emerg Med       Date:  2018-05-10       Impact factor: 5.721

8.  Cognitive, mood and quality of life impairments in a select population of ARDS survivors.

Authors:  Mark E Mikkelsen; William H Shull; Rosette C Biester; Darren B Taichman; Sarah Lynch; Ejigayehu Demissie; John Hansen-Flaschen; Jason D Christie
Journal:  Respirology       Date:  2009-01       Impact factor: 6.424

Review 9.  The case for and against fluid restriction and occlusion pressure reduction in adult respiratory distress syndrome.

Authors:  D P Schuster
Journal:  New Horiz       Date:  1993-11

10.  Clinical risk conditions for acute lung injury in the intensive care unit and hospital ward: a prospective observational study.

Authors:  Niall D Ferguson; Fernando Frutos-Vivar; Andrés Esteban; Federico Gordo; Teresa Honrubia; Oscar Peñuelas; Alejandro Algora; Gema García; Alejandra Bustos; Inmaculada Rodríguez
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  5 in total

1.  Fluid management in ARDS: an evaluation of current practice and the association between early diuretic use and hospital mortality.

Authors:  Kevin P Seitz; Ellen S Caldwell; Catherine L Hough
Journal:  J Intensive Care       Date:  2020-10-12

2.  Predictive value of computed tomography for short-term mortality in patients with acute respiratory distress syndrome: a systematic review.

Authors:  Hiroyuki Hashimoto; Shota Yamamoto; Hiroaki Nakagawa; Yoshihiro Suido; Shintaro Sato; Erina Tabata; Satoshi Okamori; Takuo Yoshida; Koichi Ando; Shigenori Yoshitake; Yohei Okada
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

3.  Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study.

Authors:  Jean-Philippe Kevorkian; Jean-Pierre Riveline; Claire Vandiedonck; Diane Girard; Joris Galland; Florine Féron; Jean-François Gautier; Bruno Mégarbane
Journal:  J Infect       Date:  2020-09-01       Impact factor: 6.072

Review 4.  Therapeutic Benefits of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome: Potential Mechanisms and Challenges.

Authors:  Chao Cao; Lin Zhang; Fuli Liu; Jie Shen
Journal:  J Inflamm Res       Date:  2022-09-10

5.  Impact of rs174537 on Critically Ill Patients with Acute Lung Injury: A Secondary Analysis of the OMEGA Randomized Clinical Trial.

Authors:  Beverly Dosso; Charlotte Mae K Waits; Kelli N Simms; Susan Sergeant; D Clark Files; Timothy D Howard; Carl D Langefeld; Floyd H Chilton; Elaheh Rahbar
Journal:  Curr Dev Nutr       Date:  2020-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.